- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Malignancies Multiple in United States
Total 5220 results
-
Masonic Cancer Center, University of MinnesotaCompleted
-
Rafic Farah, MDCompletedLymphoma | Leukemia | Myelofibrosis | MDSUnited States
-
National Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol Specific | Hematopoietic/Lymphoid CancerUnited States
-
West Virginia UniversityRecruitingNeutropenia | Hematological MalignancyUnited States
-
Kessler FoundationActive, not recruitingMultiple Sclerosis | Relapsing-remitting Multiple SclerosisUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedRelapsing-remitting Multiple SclerosisUnited States, Germany
-
University of Michigan Rogel Cancer CenterGenzyme, a Sanofi CompanyCompletedLeukemia | Multiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin Lymphoma | Myelodysplastic SyndromeUnited States
-
Clavis PharmaCompletedAML | Hematologic MalignanciesUnited States, United Kingdom, France, Germany, Italy, Norway
-
St. Jude Children's Research HospitalCompleted
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Regeneron PharmaceuticalsSanofiCompletedAdvanced Cancer | Advanced MalignanciesUnited States, Spain, Australia
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited States, Germany, Italy, United Kingdom, Canada, France, Korea, Republic of, Netherlands
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedChildhood Acute Myeloid Leukemia/Other Myeloid MalignanciesUnited States
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
National Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Epizyme, Inc.WithdrawnRefractory Hematologic Malignancy | Relapsed Hematologic MalignancyUnited States
-
AstraZenecaTerminatedStudy of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological MalignanciesHaematological MalignanciesFrance, Italy, United States, Korea, Republic of, Germany, Australia
-
University of Alabama at BirminghamWashington University School of Medicine; United States Department of DefenseRecruitingRelapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Ohio State University Comprehensive Cancer CenterCompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
University of Alabama at BirminghamRecruitingInjury; Muscle, Ankle, and Foot, MultipleUnited States
-
Anthony Sung, MDMassachusetts General HospitalCompleted
-
Northeast Iowa Medical Education FoundationUnknownChronic Conditions, MultipleUnited States
-
University of ChicagoCompletedLymphoma | Leukemia | MyelomaUnited States
-
Janssen Research & Development, LLCActive, not recruitingHematological MalignanciesCanada, United States, France, Italy, United Kingdom, Germany, Belgium, Netherlands, Spain, Sweden, China
-
Shirley Ryan AbilityLabNorthwestern UniversityNot yet recruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveUnited States
-
Icahn School of Medicine at Mount SinaiWithdrawnRelapsing-remitting Multiple Sclerosis (RRMS)United States
-
University of UtahElevar TherapeuticsTerminatedUrothelial Carcinoma | Advanced Malignancies | Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma | MSI-H or dMMR Solid TumorsUnited States
-
Erasca, Inc.WithdrawnAcute Myeloid LeukemiaUnited States
-
Community Cancer CareAmgenUnknownCancer | Solid Tumor | Hematologic MalignancyUnited States
-
University of LouisvilleRecruitingRelapsing Remitting Multiple SclerosisUnited States
-
Johns Hopkins UniversityGlaxoSmithKlineTerminatedMultiple SclerosisUnited States
-
Johns Hopkins UniversityCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Case Comprehensive Cancer CenterCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
Beckman Coulter, Inc.Completed
-
National Cancer Institute (NCI)CompletedMultiple Endocrine Neoplasia Type 2A | Multiple Endocrine Neoplasia Type 2B | Medullary Thyroid CarcinomaUnited States
-
University of Wisconsin, MadisonNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingChronic Conditions, MultipleUnited States
-
University of Alabama at BirminghamTerminatedMultiple Myeloma | Mantle Cell Lymphoma | Non Hodgkin's Lymphoma | CLL / SLL | WaldenstromsUnited States
-
Shirley Ryan AbilityLabNational Multiple Sclerosis SocietyNot yet recruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveUnited States
-
Shirley Ryan AbilityLabEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis-Relapsing-RemittingUnited States
-
National Cancer Institute (NCI)CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCancer and Aging Research GroupRecruitingLymphoma | Leukemia | MyelomaUnited States
-
Abramson Cancer Center at Penn MedicineRecruitingMDS | Leukemia, AcuteUnited States
-
Fred Hutchinson Cancer CenterNational Heart, Lung, and Blood Institute (NHLBI)CompletedAssociations Between Pre-transplant Comorbidities and Post-transplant Toxicities and Quality of LifeHematologic Malignancies | Other Diagnoses, Comorbidities, and ComplicationsUnited States
-
Arcus Biosciences, Inc.Gilead SciencesRecruitingGastrointestinal Tract MalignanciesUnited States, Korea, Republic of, France, Serbia, Canada
-
Banner Life Sciences LLCCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Washington University School of MedicineNational Institute of Mental Health (NIMH); New York University; University of... and other collaboratorsCompletedComparison Group | Multiple Family Groups by Parent Peers | Multiple Family Groups by Community Health WorkersUnited States, Ghana, Uganda, Kenya
-
LAPIX Therapeutics Inc.RecruitingMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Bristol-Myers SquibbCompletedB-Cell MalignanciesUnited States